Keyphrases
Immunoreactivity
100%
SALL4
100%
Prognosis Prediction
100%
Hepatocellular Carcinoma Patients
100%
Hepatocellular Carcinoma
50%
Overall Survival
25%
Recurrence-free Survival
25%
Immunohistochemistry
12%
Clinical Significance
12%
Tissue Microarray
12%
Nonalcoholic Steatohepatitis
12%
Alcoholic Liver Disease
12%
Tumor Grade
12%
Univariate Analysis
12%
Poor Prognosis
12%
Patients with Cancer
12%
African American
12%
Microarray
12%
Hepatitis C
12%
Native American
12%
Lymphovascular Invasion
12%
Tumor Tissue
12%
Hispanic
12%
Asia
12%
Prognostic Biomarker
12%
Etiological Factors
12%
Hepatitis B
12%
Stem Cell Markers
12%
Non-reactivity
12%
Non-tumor Tissue
12%
Liver Hepatitis
12%
Short-term Recurrence
12%
Universal Applicability
12%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Immunoreactivity
100%
Biological Marker
33%
Neoplasm
33%
Overall Survival
33%
Recurrence Free Survival
33%
Immunohistochemistry
16%
Prevalence
16%
Upregulation
16%
Tissue Microarray
16%
Nonalcoholic Fatty Liver
16%
Univariate Analysis
16%
Hepatitis C
16%
Hepatitis B
16%
Stem Cell
16%
Cell Marker
16%
Lymphovascular Invasion
16%
Alcohol Liver Disease
16%
Etiology
16%
Nursing and Health Professions
Liver Cell Carcinoma
100%
Neoplasm
33%
Overall Survival
33%
Biological Marker
33%
Recurrence Free Survival
33%
Hepatitis C
16%
Univariate Analysis
16%
Prevalence
16%
Hepatitis B
16%
Cell Marker
16%
Nonalcoholic Fatty Liver
16%
Tissue Microarray
16%
Tissue Section
16%
Immunohistochemistry
16%
Alcohol Liver Disease
16%
Lymph Vessel Metastasis
16%
Etiology
16%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Neoplasm
33%
Biological Marker
33%
Overall Survival
33%
Recurrence Free Survival
33%
Malignant Neoplasm
16%
Nonalcoholic Fatty Liver
16%
Prevalence
16%
Hepatitis C
16%
Hepatitis B
16%
Cell Marker
16%
Alcohol Liver Disease
16%
Lymph Vessel Metastasis
16%
Etiology
16%
Biochemistry, Genetics and Molecular Biology
Immunoreactivity
100%
SALL4
100%
Overall Survival
25%
Recurrence Free Survival
25%
Upregulation
12%
Prevalence
12%
Tissue Microarray
12%
Stem Cell Marker
12%
Tissue Section
12%